Global Filters




Tiers


Species


Attribution

Filter by Tier
Filter by Species
Filter by Attributions
like "mouse, Ap3m2, alcohol"

Search results are limited to 1000 results out of 2304. Try refining your search.

Returning 1000 results: Page 1 of 40


Tier Species Size Attr. GeneSet
Tier I 12 GS268946: GWAS Catalog Data for velocity of sound measurement in 2,483 East Asian ancestry individuals, 1,885 European ancestry individuals, 11,146 individuals
Tier I 10 GS268947: GWAS Catalog Data for bone quantitative ultrasound measurement in 730 East Asian ancestry individuals, 2,380 European ancestry individuals, 11,150 individuals
Tier I 88 GS270655: GWAS Catalog Data for bone density in Up to 32,961 European and East Asian ancestry individuals
Tier I 28 GS270770: GWAS Catalog Data for bone density in 19,195 European ancestry individuals
Tier IV 18653 GS407376: Dysregulation of NRSF/REST via EHMT1 is associated with psychiatric disorders and Kleefstra syndrome
Tier IV 5317 GS407636: Differential gene expression comparison between Carnegie Stages (CS) 13 and 17 during human embryo craniofacial development
Tier III 19901 GS407933: Differentially expressed genes of post mortem human central Amygdala samples in patients affected by opioid use disorder (OUD) vs. unaffected control samples_Log2FC
Tier III 19901 GS407934: Differentially expressed genes of post mortem human central Amygdala samples in patients affected by opioid use disorder (OUD) vs. unaffected control samples_qvalue
Tier III 19111 GS407935: Differentially expressed genes in human kidney tumors associated with extended opioid exposure_logFC
Tier III 19111 GS407936: Differentially expressed genes in human kidney tumors associated with extended opioid exposure_FDR
Tier III 18513 GS407948: Differentially expressed genes in humans nucleus accumbens associated with opioid use disorder_log2FC
Tier III 18278 GS407950: Differentially expressed genes in humans dorsolateral prefrontal cortex associated with opioid use disorder_log2FC
Tier III 18278 GS407951: Differentially expressed genes in humans dorsolateral prefrontal cortex associated with opioid use disorder_qvalue
Tier IV 9363 GS408182: Differential gene expression comparison between Carnegie Stages (CS) 15 and 22 during human embryo craniofacial development, log2FC
Tier IV 10391 GS408185: Differential gene expression comparison between Carnegie Stages (CS) 13 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 9299 GS408186: Differential gene expression comparison between Carnegie Stages (CS) 17 and 22 during human embryo craniofacial development, log2FC
Tier IV 9299 GS408188: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 10134 GS408189: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, log2FC
Tier IV 10134 GS408190: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 8709 GS391: RIKEN Cerebellum C57BL/6J Development Series
Tier III 637 GS826: UCSD_CEREBELLUM_Interaction_Reduced_Age_4th
Tier III 428 GS836: Differential expression in Sey Pax6 mutants and controls. Additive effect of mutation, linear increase in both mutants and Wild-types.
Tier III 148 GS1026: SEY WT E12, E15, E18 contrast analysis where Helmert(1v2) q-value < .05 and Helmert (12v3) q-value < .05.
Tier III 279 GS14907: Nicotine Dependence Genes found in Genome-wide Association Studies (GWAS)
Tier III 42 GS26277: Whole Brain Gene expression correlates of Mechanical Sensitivity-Von Frey Threshold [Pain] in Males BXD